The Current Ratio as of September 2024 (TTM) for PLx Pharma Inc. (PLXP) is 6.19

According to PLx Pharma Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.19. This represents a change of 24.25% compared to the average of 4.98 of the last 4 quarters.

PLx Pharma Inc. (PLXP) Historical Current Ratio (quarterly & annually)

How has PLXP Current Ratio performed in the past?

The mean historical Current Ratio of PLx Pharma Inc. over the last ten years is 9.58. The current 6.19 Current Ratio has changed 6.36% with respect to the historical average. Over the past ten years (40 quarters), PLXP's Current Ratio was at its highest in in the March 2021 quarter at 60.22. The Current Ratio was at its lowest in in the March 2013 quarter at 0.

PLx Pharma Inc. (PLXP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of PLx Pharma Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PLx Pharma Inc. (PLXP) Average Current Ratio

How has PLXP Current Ratio performed in the past?

The current Current Ratio of PLx Pharma Inc. (PLXP) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

PLx Pharma Inc. (PLXP) Current Ratio vs. Peers

How is PLXP’s Current Ratio compared to its peers?

PLx Pharma Inc.’s Current Ratio is greater than Biofrontera Inc. (1.89), less than Guardion Health Sciences, Inc. (16.67), greater than Shuttle Pharmaceuticals Holdings, Inc. (1.79), greater than Akanda Corp. (0.18), greater than China Pharma Holdings, Inc. (0.84), greater than Cann American Corp. (0.02), greater than Acorda Therapeutics, Inc. (0.22), greater than Kala Pharmaceuticals, Inc. (3.07), greater than Mallinckrodt plc (0.57), greater than Halo Collective Inc. (1.47), greater than Alimera Sciences, Inc. (2.79), greater than China SXT Pharmaceuticals, Inc. (1.60), greater than Petros Pharmaceuticals, Inc. (1.40), greater than Societal CDMO, Inc. (1.07), greater than Organogenesis Holdings Inc. (2.73), greater than Lifecore Biomedical, Inc. (2.08), greater than OptiNose, Inc. (3.94),

Build a custom stock screener for PLx Pharma Inc. (PLXP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PLx Pharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PLx Pharma Inc. (PLXP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PLx Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.